GHK-Cu (Copper Peptide) Clinical Evidence Guide: 2026 Medical Standards
Last updated: June 7, 2026 GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is an endogenous tripeptide that dictates the body’s response to tissue injury, oxidative stress, and aging. Under 2026 medical standards, it is deployed not merely as a cosmetic dermatology agent, but as a systemic epigenetic modulator that resets the expression of over 4,000 human genes associated … Read more